HyperopiaNCT07276347
Comprehensive Assessment of Multiple Products (CAMP)
A study testing somofilcon A lens, stenfilcon A lens and fanfilcon A lens in people with Hyperopia and Myopia, run by CooperVision International Limited (CVIL) at 1 site in United States.
Trial summary
The aim of this study is to assess contact lens performance and acceptance. Read more about this study
- Who is it for?
- Ages 18 to 45 years
- What is being tested?
- somofilcon A lens, stenfilcon A lens and fanfilcon A lens
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteUnited States
- Study dates
- 12 Nov 2025to 17 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Age 18 to 45 years (inclusive)
- Habitual soft spherical contact lens wearer (current prescription)
- Refractive error of -6.00 to -0.50DS or +0.50 to +6.00DS and less than or equal to 0.75DC as vertexed to the corneal plane
- Anisometropia no greater than 1.50D, based on vertexed manifest refraction spherical equivalent
- Can achieve visual acuity of at least 20/25 in each eye with spherical equivalent manifest refraction
Who cannot join
- Active anterior segment infection, inflammation or abnormality that would contraindicate contact lens wear
- Use of systemic or ocular medication that would contraindicate contact lens wear
- Used gas permeable/hard contact lenses (including orthokeratology) in the previous 3 months
- Participation in a contact lens or lens care product trial in the previous 30 days
Trial locations and contacts
1 site in 1 country.
About this study
The aim of this study is to assess contact lens performance and acceptance.
Read the detailed description
The objective of this study is to assess the initial performance and acceptance of a range of contact lenses in habitual soft contact lens wearers.
- Being tested
- somofilcon A lens, stenfilcon A lens, fanfilcon A lens, comfilcon A lens, verofilcon A lens
- Medical subject headings
- Hyperopia, Myopia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
somofilcon A lensDevice
Participants will be randomized to wear somofilcon A soft contact lens for 10 hours.
stenfilcon A lensDevice
Participants will be randomized to wear stenfilcon A soft contact lens for 10 hours.
fanfilcon A lensDevice
Participants will be randomized to wear fanfilcon A soft contact lens for 10 hours.
comfilcon A lensDevice
Participants will be randomized to wear comfilcon A soft contact lens for 10 hours.
verofilcon A lensDevice
Participants will be randomized to wear verofilcon A soft contact lens for 10 hours.
serafilcon A lensDevice
Participants will be randomized to wear serafilcon A soft contact lens for 10 hours.
lehfilcon A lensDevice
Participants will be randomized to wear lehfilcon A soft contact lens for 10 hours.
delefilcon A lensDevice
Participants will be randomized to wear delefilcon A soft contact lens for 10 hours.
senofilcon A daily disposable lensDevice
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
senofilcon A with blue light technology lensDevice
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
senofilcon A bi-weekly lensDevice
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
samfilcon A lensDevice
Participants will be randomized to wear samfilcon A soft contact lens for 10 hours.
kalilfilcon A lensDevice
Participants will be randomized to wear kalifilcon A soft contact lens for 10 hours.
| Study group | Role | What they receive |
|---|---|---|
| somofilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: somofilcon A lens |
| stenfilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: stenfilcon A lens |
| fanfilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: fanfilcon A lens |
| comfilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: comfilcon A lens |
| verofilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: verofilcon A lens |
| serafilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: serafilcon A lens |
| lehfilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: lehfilcon A lens |
| delefilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: delefilcon A lens |
| senofilcon A lens daily disposable | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: senofilcon A daily disposable lens |
| senofilcon A lens with blue light technology | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: senofilcon A with blue light technology lens |
| senofilcon A lens bi-weekly replacement | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: senofilcon A bi-weekly lens |
| samfilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: samfilcon A lens |
| kalifilcon A lens | Experimental | Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. Receives: Device: kalilfilcon A lens |
What is being measured
The primary outcome is the main question the study is designed to answer.
High contrast, high luminance binocular distance visual acuity
High contrast, high luminance binocular distance visual acuity (logMAR) will be measured at 10-hour visit.
Measured: At the end of 10 hours of daily wear at dispensing
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Dec 2025
- Study start12 Nov 2025
- Primary completion17 Dec 2025
- Study completion17 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HyperopiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- CooperVision International Limited (CVIL)
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Pete Kollbaum, OD, PhD, Principal investigator, Indiana University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07276347
- Sponsor's protocol ID
- EX-MKTG-167
- Status last verified
- Apr 2026
- First submitted
- 1 Dec 2025
- Last updated
- 13 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comprehensive Assessment of Multiple Products (CAMP)
- ClinicalTrials.gov ID
- NCT07276347
- Acronym / sponsor ID
- EX-MKTG-167
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- CooperVision International Limited (CVIL)Industry (pharma, biotech, devices)
- Study start
- 12 Nov 2025 (actual)
- Primary completion
- 17 Dec 2025 (actual)
- Study completion
- 17 Dec 2025 (actual)
- First posted
- 11 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to assess contact lens performance and acceptance.
Detailed description
The objective of this study is to assess the initial performance and acceptance of a range of contact lenses in habitual soft contact lens wearers.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 13
| Arm | Type | Receives |
|---|---|---|
| somofilcon A lens | Experimental | Device: somofilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| stenfilcon A lens | Experimental | Device: stenfilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| fanfilcon A lens | Experimental | Device: fanfilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| comfilcon A lens | Experimental | Device: comfilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| verofilcon A lens | Experimental | Device: verofilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| serafilcon A lens | Experimental | Device: serafilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| lehfilcon A lens | Experimental | Device: lehfilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| delefilcon A lens | Experimental | Device: delefilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| senofilcon A lens daily disposable | Experimental | Device: senofilcon A daily disposable lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| senofilcon A lens with blue light technology | Experimental | Device: senofilcon A with blue light technology lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| senofilcon A lens bi-weekly replacement | Experimental | Device: senofilcon A bi-weekly lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| samfilcon A lens | Experimental | Device: samfilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
| kalifilcon A lens | Experimental | Device: kalilfilcon A lensParticipants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Age 18 to 45 years (inclusive)
- Habitual soft spherical contact lens wearer (current prescription)
- Refractive error of -6.00 to -0.50DS or +0.50 to +6.00DS and less than or equal to 0.75DC as vertexed to the corneal plane
- Anisometropia no greater than 1.50D, based on vertexed manifest refraction spherical equivalent
- Can achieve visual acuity of at least 20/25 in each eye with spherical equivalent manifest refraction
Key exclusion criteria (4 listed)
- Active anterior segment infection, inflammation or abnormality that would contraindicate contact lens wear
- Use of systemic or ocular medication that would contraindicate contact lens wear
- Used gas permeable/hard contact lenses (including orthokeratology) in the previous 3 months
- Participation in a contact lens or lens care product trial in the previous 30 days
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| somofilcon A lensParticipants will be randomized to wear somofilcon A soft contact lens for 10 hours. | Device | somofilcon A lens |
| stenfilcon A lensParticipants will be randomized to wear stenfilcon A soft contact lens for 10 hours. | Device | stenfilcon A lens |
| fanfilcon A lensParticipants will be randomized to wear fanfilcon A soft contact lens for 10 hours. | Device | fanfilcon A lens |
| comfilcon A lensParticipants will be randomized to wear comfilcon A soft contact lens for 10 hours. | Device | comfilcon A lens |
| verofilcon A lensParticipants will be randomized to wear verofilcon A soft contact lens for 10 hours. | Device | verofilcon A lens |
| serafilcon A lensParticipants will be randomized to wear serafilcon A soft contact lens for 10 hours. | Device | serafilcon A lens |
| lehfilcon A lensParticipants will be randomized to wear lehfilcon A soft contact lens for 10 hours. | Device | lehfilcon A lens |
| delefilcon A lensParticipants will be randomized to wear delefilcon A soft contact lens for 10 hours. | Device | delefilcon A lens |
| senofilcon A daily disposable lensParticipants will be randomized to wear senofilcon A soft contact lens for 10 hours. | Device | senofilcon A lens daily disposable |
| senofilcon A with blue light technology lensParticipants will be randomized to wear senofilcon A soft contact lens for 10 hours. | Device | senofilcon A lens with blue light technology |
| senofilcon A bi-weekly lensParticipants will be randomized to wear senofilcon A soft contact lens for 10 hours. | Device | senofilcon A lens bi-weekly replacement |
| samfilcon A lensParticipants will be randomized to wear samfilcon A soft contact lens for 10 hours. | Device | samfilcon A lens |
| kalilfilcon A lensParticipants will be randomized to wear kalifilcon A soft contact lens for 10 hours. | Device | kalifilcon A lens |
Primary outcome
High contrast, high luminance binocular distance visual acuity
Time frame: At the end of 10 hours of daily wear at dispensing
High contrast, high luminance binocular distance visual acuity (logMAR) will be measured at 10-hour visit.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2026.
Related trials for Hyperopia
Active, not recruiting
Clinical Trial With Artiflex Presbyopic (Artiplus)
Presbyopia, Ametropia
Not yet recruiting
The Emmetropization Via Accommodation (EVA) - II Study
Hyperopia, Farsightedness
Recruiting
Eye Imaging for the Study of Childhood Myopia
Hyperopia and Myopia
Recruiting
School-based Myopia Prevention Trial for Children With Insufficient Hyperopic Reserve
Refractive Errors, Hyperopia
Recruiting
School-based Myopia Prevention Trial for Children With Adequate Hyperopic Reserve
Myopia, Refractive Errors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pete Kollbaum, OD, PhD principal investigator
Indiana University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing somofilcon A lens, stenfilcon A lens and fanfilcon A lens in people with Hyperopia and Myopia, run by CooperVision International Limited (CVIL) at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
High contrast, high luminance binocular distance visual acuity (time frame: At the end of 10 hours of daily wear at dispensing). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.